Evidence map›Paper›PMID 26587300›Full record

ArticleCase reports in genetics2015

Whole Exome Sequencing Reveals Compound Heterozygosity for Ethnically Distinct PEX7 Mutations Responsible for Rhizomelic Chondrodysplasia Punctata, Type 1.

Jessie C Jacobsen, Emma Glamuzina, Juliet Taylor, Brendan Swan, Shona Handisides, Callum Wilson, Michael Fietz, Tessa van Dijk, Bart Appelhof, Rosamund Hill and 5 more

Open access · goldAbstract read
In one paragraph

Article in Case reports in genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Jessie C JacobsenCentre for Brain Research and School of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand.
Emma GlamuzinaAdult and Paediatric National Metabolic Service, Auckland City Hospital, Auckland 1142, New Zealand.
Juliet TaylorGenetic Health Service New Zealand, Auckland City Hospital, Auckland 1142, New Zealand.
Brendan SwanCentre for Brain Research and School of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand.
Shona HandisidesDepartment of Radiology, Auckland City Hospital, Auckland 1142, New Zealand.
Callum WilsonAdult and Paediatric National Metabolic Service, Auckland City Hospital, Auckland 1142, New Zealand.
Michael FietzDepartment of Biochemical Genetics, SA Pathology, North Adelaide, SA 5006, Australia ; Department of Diagnostic Genomics, PathWest, Nedlands, WA 6009, Australia.
Tessa van DijkDepartment of Genome Analysis, Academic Medical Centre, 1105 Amsterdam, Netherlands.
Bart AppelhofDepartment of Genome Analysis, Academic Medical Centre, 1105 Amsterdam, Netherlands.
Rosamund HillDepartment of Neurology, Auckland City Hospital, Auckland 1142, New Zealand.
Rosemary MarksDevelopmental Paediatric Service, Starship Children's Health, Auckland 1142, New Zealand.
Donald R LoveDiagnostic Genetics, LabPLUS, Auckland City Hospital, Auckland 1142, New Zealand.
Stephen P RobertsonDunedin School of Medicine, University of Otago, Dunedin 9016, New Zealand.
Russell G SnellCentre for Brain Research and School of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand.
Klaus LehnertCentre for Brain Research and School of Biological Sciences, The University of Auckland, Auckland 1010, New Zealand.
Auckland City Hospital · NZUniversity of Auckland · NZAmsterdam UMC Location University of Amsterdam · NLSouth Australia Pathology · AUStarship Children's Health · NZUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe two brothers who presented at birth with bone growth abnormalities, followed by development of increasingly severe intellectual and physical disability, growth restriction, epilepsy, and cerebellar and brain stem atrophy, but normal ocular phenotypes. Case 1 died at 19 years of age due to chronic respiratory illnesses without a unifying diagnosis. The brother remains alive but severely disabled at 19 years of age. Whole exome sequencing identified compound heterozygous stop mutations in the peroxisome biogenesis factor 7 gene in both individuals. Mutations in this gene cause rhizomelic chondrodysplasia punctata, type 1 (RCDP1). One mutation, p.Arg232 (∗) , has only been documented once before in a Japanese family, which is of interest given these two boys are of European descent. The other mutation, p.Leu292 (∗) , is found in approximately 50% of RCDP1 patients. These are the first cases of RCDP1 that describe the coinheritance of the p.Arg232 (∗) and p.Leu292 (∗) mutations and demonstrate the utility of WES in cases with unclear diagnoses.

Identifiers

PMID26587300
PMCPMC4637447
OpenAlexW1870967538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.